RetiSpec is a medical imaging company using advanced Artificial Intelligence to develop a screening tool for early and accurate detection of Alzheimer’s disease markers in the eye.
RetiSpec’s proprietary technology provides a non-invasive and more widely available solution for the early detection of Alzheimer’s disease than current methods of assessment.
Field: Medical Imaging
Headquarters: Toronto, ON
ELIAV SHAKED, M.SC
CEO & Co-founder
Eliav is a biomedical engineer with 7+ years experience managing R&D projects and having led several medical products from ideation to launch. He holds a B.Sc and M.Sc in Biomedical Engineering from Tel-Aviv University.
ADAM GRIBBLE, PHD
Adam has 7 years of hands-on experience in both fundamental and applied optics research, including bio-imaging, spectral analysis, and development of optical instrumentation.
MAÏLIS BIETENHADER, PHD
Ocular Imaging Specialist
Mailis is an expert in ophthalmic imaging. After a PhD in Molecular Biology and a successful post-doctoral fellowship at the University of Toronto, she combines her background in research with 6 years of clinical experience.
ROY KIRSHON, MBA
COO & Co-founder
Roy is a biomedical engineer, and an MBA. With 10 years of experience building new initiatives and working with ventures, Roy has led new technologies and early stage startups to market.
ALON HAZAN, M.SC
Head of AI
Alon is an expert in artificial intelligence, deep learning and machine learning, and is a computer-vision researcher with over 10 years of industry experience, which includes designing two FDA approved AIs.
CATHERINE BORNBAUM, PHD, MBA
Head of Clinical Operations & Partnerships
Catherine is a health scientist and MBA with 10+ years of experience leading large-scale health research operations. In 2019, she was named one of the 100 Best & Brightest Executive MBAs globally by Poets & Quants.
JARED WESTREICH, M.SC
Jared is an experienced data scientist with a background in medical biophysics and expertise in machine learning techniques.